1 July 2024 pathology MBS changes

This page provides information on the 1 July 2024 changes to MBS pathology items.

Page last updated: 25 June 2024

From 1 July 2024, the following new and amended pathology items will be listed on the MBS. Further information can be found in the factsheets below:

Fact Sheet
PDF and Word versions
Detection of measurable residual disease (MRD) using a quantitative patient-specific molecular assay for patients with acute lymphoblastic leukaemia (ALL)

Last updated: 31 May 2024

Word Version - Detection of MRD using a quantitative patient-specific molecular assay for patients with ALL (Word 126 KB)

PDF Version - Detection of MRD using a quantitative patient-specific molecular assay for patients with ALL (PDF 235 KB)

Amendment of MBS item 73410 to extend carrier testing for Alpha thalassaemia (and other minor amendments to items 73410, 73411, 73412 and 73413)

Last updated: 31 May 2024
Word Version - Amendment of MBS item 73410 to extend carrier testing for Alpha thalassaemia and other minor amendments to items 73410, 73411, 73412 and 73413 (Word 127 KB)

PDF Version - Amendment of MBS item 73410 to extend carrier testing for Alpha thalassaemia and other minor amendments to items 73410, 73411, 73412 and 73413 (PDF 233 KB)

Quantification of BNP or NT-proBNP in patients with previously diagnosed pulmonary arterial hypertension (PAH) – new item 66586

Last updated: 31 May 2024

Word Version - Quantification of BNP or NT-proBNP in patients with previously diagnosed pulmonary arterial hypertension (PAH) – new item 66586 (Word 126 KB)

PDF Version - Quantification of BNP or NT-proBNP in patients with previously diagnosed pulmonary arterial hypertension (PAH) – new item 66586 (PDF 200 KB)

Permanent Medicare Benefits Schedule items for testing respiratory pathogens including COVID-19

Last updated: 31 May 2024

Word Version - Permanent Medicare Benefits Schedule items for testing respiratory pathogens including COVID-19 (Word 127 KB)

PDF Version - Permanent Medicare Benefits Schedule items for testing respiratory pathogens including COVID-19 (PDF 228 KB)

Expansion of BRCA1 and BRCA2 germline variant testing item for patients with HER2 negative breast cancer – Amended item 73295

Last updated: 31 May 2024
Word Version - Expansion of BRCA1 and BRCA2 germline variant testing item for patients with HER2 negative breast cancer – Amended item 73295 (Word 128 KB)

PDF Version - Expansion of BRCA1 and BRCA2 germline variant testing item for patients with HER2 negative breast cancer – Amended item 73295 (PDF 211 KB)

In this section